Post Date December, 03 2023
Prostate cancer bone metastasis treatment? Prostate cancer is a common disease in our lives, and it poses great harm to men. Therefore, we must take our physical and mental health seriously. So, how to treat prostate cancer with bone metastasis? Prostate cancer can metastasize at any time, but it is most common from now on. Prostate cancer has bone metastasis, and pain is the primary manifestation. Persistent dull pain often affects the patient's appetite and daily life rhythm, leading to the patient becoming increasingly thin and suffering.
Bone metastasis is one of the most common complications of malignant tumors, with a incidence rate of 20%~30% in tumor patients. Bone metastasis is especially common in multiple myeloma (70%~95%), breast cancer (65%~75%), prostate cancer (65%~75%), lung cancer (30%~40%), etc. Its main symptoms are gradually aggravated severe pain, and in the late stage, there are even pathological fractures, spinal cord and nerve compression, and related bone events, often because of severe pain and fractures, long-term bedridden. Research has shown that more than half of patients are bedridden due to skeletal complications before treatment, while after targeted treatment, more than 85% of patients can take care of themselves within 7 days, saving them the cost of care and repeated medical treatment caused by long-term bed rest. Experts emphasize that updating the traditional concept of palliative pain relief in the treatment of cancer patients with bone metastasis, taking targeted treatment measures to improve their quality of life, and providing patients with a painless survival period have become urgent matters.
Early bone metastasis in prostate cancer often has no clinical symptoms, but the most common and earliest clinical manifestation of bone metastasis in prostate cancer is bone pain. Once patients experience bone pain, it indicates that most patients with prostate cancer have advanced to the late stage of the prostate and have lost the best treatment opportunity. Prostate cancer can spread to any tissue or organ throughout the body through hematogenous metastasis, with the most common distant metastatic site being the bone. The initial stage of bone metastasis from prostate cancer is often asymptomatic, and in severe cases, it can be accompanied by pain, fatigue, and dysfunction. The most common phenomena in laboratory examinations of prostate cancer patients with bone metastasis are an increase in serum PSA value, an increase in serum alkaline phosphatase, and anemia. Radionuclide bone scanning is currently the most commonly used imaging examination method for diagnosing bone metastasis due to its high sensitivity.
(Intern Editor: Xie Yunsheng)
